Contraline Secures $2.25 M in Seed Financing

News | Thursday, April 13th, 2017

CHARLOTTESVILLE, Virginia — Contraline, a biotechnology company developing a novel male contraceptive, announced it has raised $2.25 million in Seed funding. The round was led by San Francisco-based venture capital firm, Founders Fund, with investments also coming from Center for Innovative Technology, Abstract Ventures, Afton Scientific, and angel investors including Jaffray Woodriff and Jason Calacanis. […]

Contraline Accelerates Growth with Expansion into New Laboratories and Addition of Key Team Members

News | Thursday, December 8th, 2016

CHARLOTTESVILLE, Virginia — Earlier this fall, Contraline moved its operations from the University of Virginia School of Medicine into its new headquarters in Charlottesville, called “ContraLab.” ContraLab is a 2200 sq. ft. office and laboratory space located at 1216 Harris Street. The laboratory space will be used primarily for research and product development including synthesizing […]

Contraline Awarded $50,000 from Center for Innovative Technology

News | Monday, June 13th, 2016

CHARLOTTESVILLE, Virginia – Contraline is excited to announce its selection as an awardee for the 2016 Research Commercialization Award. This distinction is supported by the Center for Innovative Technology’s Commonwealth Research Commercialization Fund (CRCF). The mission of this fund is to accelerate innovation and economic growth in Virginia by advancing solutions to important state, national, […]

Contraline Raises $700,000 in Seed Funding from Angel Investors

News | Friday, June 3rd, 2016

CHARLOTTESVILLE, Virginia – Contraline, a University of Virginia founded biotechnology company developing a new form of male birth control, today officially announced the successful closing of its seed round at $700,000. Led by CEO of Tydall Trading LLC Mark Galant, the funding round also includes investments from Kima Ventures (a Paris-based early stage venture fund […]

Contraline is accepted into Y Combinator Fellowship

News | Friday, May 13th, 2016

This summer, Contraline will be a part of Y Combinator’s Fellowship program! Y Combinator is one of the top startup accelerators in the world having funded companies like Airbnb, Dropbox, and Stripe. Recently, Y Combinator has been investing in more biotech companies given the incredible technology, economical, and social impact these companies are having. The fellowship program (only […]

Contraline places second in the Inaugural ACC Inventure Prize

News | Thursday, May 12th, 2016

Charlottesville, VA – On April 6th, Georgia Tech hosted the inaugural ACC Inventure Prize in Atlanta, Georgia. The event highlighted undergraduate entrepreneurs from each Atlantic Coast Conference school who competed for $30,000 in cash prizes. Representing the University of Virginia was team Contraline, a biotechnology and medical device company developing a novel male contraceptive. Co-founder Kevin Eisenfrats pitched […]

Search the news